000 | 01323 a2200409 4500 | ||
---|---|---|---|
005 | 20250515124101.0 | ||
264 | 0 | _c20080903 | |
008 | 200809s 0 0 eng d | ||
022 | _a1812-9269 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJantova, S | |
245 | 0 | 0 |
_aAntiproliferative activity and apoptosis induced by 6-bromo-2-(morpholin-1-yl)-4-anilinoquinazoline on cells of leukemia lines. _h[electronic resource] |
260 |
_bExperimental oncology _cJun 2008 |
||
300 |
_a139-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAniline Compounds _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 | _aDNA Fragmentation |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 | _aHL-60 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMicroscopy, Fluorescence |
650 | 0 | 4 | _aModels, Chemical |
650 | 0 | 4 |
_aQuinazolines _xpharmacology |
650 | 0 | 4 | _aU937 Cells |
700 | 1 | _aRepicky, A | |
700 | 1 | _aPaulovicova, E | |
700 | 1 | _aLetasiova, S | |
700 | 1 | _aCipak, L | |
773 | 0 |
_tExperimental oncology _gvol. 30 _gno. 2 _gp. 139-42 |
|
999 |
_c18051013 _d18051013 |